Checkpoint Therapeutics, Inc. Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • Checkpoint Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -673 %, a 41% decline year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2023 was -950 %, a 317% decline from 2022.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2022 was -228 %, a 146% decline from 2021.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2021 was -92.8 %, a 31.8% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -950 -722 -317% Jan 1, 2023 Dec 31, 2023
2022 -228 -135 -146% Jan 1, 2022 Dec 31, 2022
2021 -92.8 -22.4 -31.8% Jan 1, 2021 Dec 31, 2021
2020 -70.4 +67.7 +49% Jan 1, 2020 Dec 31, 2020
2019 -138 -18 -15% Jan 1, 2019 Dec 31, 2019
2018 -120 -37.1 -44.7% Jan 1, 2018 Dec 31, 2018
2017 -83.1 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.